| Synonyms: | |
| Status: | Approved (2020) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | M9BYU8XDQ6 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | DNA topoisomerase I inhibitor |
| Primary Target | |
|---|---|
| tumor associated calcium signal transducer 2 |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neoplasms | 4 | D009369 | ClinicalTrials |
| Endometrial Neoplasms | 3 | D016889 | ClinicalTrials |
| Endometrial Neoplasms | 3 | D016889 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 3 | D002289 | ClinicalTrials |
| Urogenital Neoplasms | 3 | D014565 | ClinicalTrials |
| Urinary Bladder Neoplasms | 2 | D001749 | ClinicalTrials |
| Glioblastoma | 2 | D005909 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
| Uterine Cervical Neoplasms | 2 | D002583 | ClinicalTrials |
| Urinary Bladder Neoplasms | 2 | D001749 | ClinicalTrials |
| Urinary Bladder Neoplasms | 2 | D001749 | ClinicalTrials |
| Klatskin Tumor | 2 | D018285 | ClinicalTrials |
| Thyroid Neoplasms | 2 | D013964 | ClinicalTrials |
| Lung Neoplasms | 2 | D008175 | ClinicalTrials |
| Mesothelioma | 2 | D008654 | ClinicalTrials |
| Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
| Brain Diseases | 2 | D001927 | ClinicalTrials |
| Esophageal Neoplasms | 2 | D004938 | ClinicalTrials |
| Thymoma | 2 | D013945 | ClinicalTrials |
| Thymoma | 2 | D013945 | ClinicalTrials |
| Stomach Neoplasms | 1 | D013274 | ClinicalTrials |
| Meningeal Carcinomatosis | 1 | D055756 | ClinicalTrials |
| Small Cell Lung Carcinoma | 1 | D055752 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1491917-83-9 |
| ChEMBL | CHEMBL3545262 |
| FDA SRS | M9BYU8XDQ6 |
| Guide to Pharmacology | 8253 |
| PubChem | 91668186 |
CONTENTS